Clinical Trials Directory

Trials / Unknown

UnknownNCT04370002

Sensor-based Characterization of Depression

Leveraging Artificial Intelligence for the Assessment of Severity of Depressive Symptoms

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a longitudinal study where individual with Major Depressive Disorder (MDD) will be monitored for 12 weeks. The study aims to develop an objective, sensor-based, algorithm able to detect the presence of depression as well as predict treatment response. Measurement-based treatment is considered optimal and the development of a valid passive, objective, behavioral and biological assessment of depressive symptoms that does not rely on clinician interviews will improve monitoring and ultimately improve treatment significantly.

Detailed description

In this longitudinal study 100 individuals with Major Depressive Disorder (MDD) will be monitored for 12 weeks. Data will include self-report surveys, in-person assessments, physiological features derived by wearable devices and socialization and activity data derived by mobile applications. The study will utilize advanced statistical methods to integrate different sources of passive sensor-based behavioral and physiological data to develop models able to detect depression and predict treatment response.

Conditions

Timeline

Start date
2020-01-28
Primary completion
2024-09-01
Completion
2024-11-30
First posted
2020-04-30
Last updated
2023-11-03

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04370002. Inclusion in this directory is not an endorsement.